The antigonadotropic activity of chloramadinone acetate;Activite antigonadotrope de l'acetate de chlormadinone

Revue du Praticien - Gynecologie et Obstetrique

Volumn , Issue 40, 2000, Pages 33-39

  Young, Jacques ^a   Brailly, Sylvie ^a   Chassard, Didier ^b   Chanson, Philippe ^a  

^a BICÊTRE HOSPITAL   (France)

^b Aster 3 5 ^*  (France)

Author keywords

Antigonadotropic activity; Chlormadinone acetate; FSH E2; LH pulsatility

Indexed keywords

CHLORMADINONE ACETATE; ESTRADIOL; FOLLITROPIN; GESTONORONE; HYDROXYPROGESTERONE; LUTEINIZING HORMONE; NANDROLONE; PROGESTERONE DERIVATIVE;

ARTICLE; DRUG ACTIVITY; DRUG TOLERANCE; FEMALE; HORMONE DETERMINATION; HUMAN; HUMAN EXPERIMENT; MENOPAUSE; NORMAL HUMAN; PULSATILE HORMONE RELEASE;

EID: 0034652775     PISSN: 12801437     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Soules MR, Steiner RA, Clifton DK, Cohen NL, Aksel S, Bremner WJ. Progesterone modulation of pulsatile luteinizing hormone secretion in normal women. J Clin Endocrinol Metab 1984 ; 58 (2) : 378-83.
2. Skinner DC, Evans NP, Delaleu B, Goodman RL, Bouchard P, Caraty A. The negative feedback actions of progesterone on gonadotropin-releasing hormone secretion are transducted by a classical progesterone receptor. Proc Natl Acad Sci 1998 ; 95 : 10978-83.
3. Couzinet B, Young J, Kujas M et al. The antigonadotropic activity of a 19-nor-progesterone derivative is exerted both at the hypothalamic and pituitary levels in women. J Clin Endocrinol Metab 1999 ; 84: 4191-6.
4. Bullock LP, Bardin CW. Androgenic, synandrogenic and antiandrogenic actions of progestins. Ann NY Acad Sci 1977 ; 286 : 321-30.
5. Neumann F. The physiological action of progesterone and the pharmacological effects of progestogens - a short review. Postgrad Med J 1978 ; 54 (suppl. 2) : 11-24.
6. Couzinet B, Young J, Brailly S, Chanson P, Thomas JL, Schaison G. The antigonadotropic activity of progestins (nor-19-progesterone and nor-19-progesterone derivatives) is not mediated through the androgen receptor. J Clin Endocrinol Metab 1996 ; 81 (12) : 4218-23.
7. Pélissier C, Basdevant A, Conard J. Administration prolongée d'acétate de chlormadinone. Effets métaboliques, tensionnels et hormonaux. Gynecologie 1991 ; 42 : 79-86.
8. Pélissier C. Tolérance clinique, métabolique et vasculaire de l'association 17b-estradiol et acétate de chlormadinone chez la femme ménopausée normale on à risque artériel. Etude prospective. Contrôlée, randomisée, à long terme (18 mois). Rev Prat Gynecol Obstet 1999 ; 29 : 35-40.
9. Chang RJ, Plouffe L, Schaffer K. Physiologie de la ménopause. In : Lorrain J, Plouffe L (eds). La ménopause : prise en charge globale et traitement. Québec : Edisem Inc. 1995 : 3-13.
10. Thomas G, Plu G, Thabalard JC. Identification of pulses in hormone time series using outlier detection methods. Stat Med 1992 ; 11 : 2133-45.
11. Pélissier C, Blacker C, Feinstein MC, Cournot A, Denis C. Action anti-ovulatoire de l'acétate de chlormadinone. Contracept Fertil Sex 1994 ; 22 (1) : 37-40.